Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: Osteochondral defect (OCD) regeneration is difficult due to the different properties and repair potentials of bone and cartilage tissues. This study aimed to compare cartilage tissue healing by applying in vitro produced double-layered and single-layered scaffolds to osteochondral defects.

Methods: Ninety male Wester Albino rats with an age of over twelve weeks and a weight of 300-350 g were included in study. Group A was the control group (isolated OCD), Group B received a cellular double-layered scaffold, Group C received a cell-free double-layered scaffold, Group D received a cellular single-layered scaffold, and Group E received a cell-free single-layered scaffold. Biodegradable double-layered and single-layered scaffolds were obtained using L-lactide-co-glycolide (PLGA) and hydroxyapatite (HA) in the bone layer, PLGA and polyethylene glycol methyl ether methacrylate (PEGMEMA) in the cartilage layer. The resulting tissues were stained with Hematoxylin-Eosin and Masson's Tricrom. Improvement was evaluated at week 4, week 8, and week 12 according to the Modified Mankin and O'Driscol scales.

Results: The positive impact of scaffold-based cellular applications on morphological field changes was demonstrated. Groups B and C exhibited higher morphological field scores compared to groups D and E. In both scoring systems, group E showed a significant long-term increase. Although the vitality of chondrocyte cells in the scaffolds was confirmed, their desired effects diminished over time. The lowest cell population scores were observed in groups B and D. Although chondrocyte cells demonstrated sustained viability in the double-layered scaffold during the early period, this effect was not observed in the mid and late periods.

Conclusions: The double-layered scaffold had a limited effect in enhancing osteochondral regeneration. The single-layered scaffold was more effective in enhancing regeneration in the late period. Given the favorable late period outcomes associated with the single-layered scaffold, we propose that further clinical and laboratory studies focus on its long-term results.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12329985PMC
http://dx.doi.org/10.1186/s13018-025-06179-zDOI Listing

Publication Analysis

Top Keywords

group received
16
double-layered scaffold
16
single-layered scaffold
16
double-layered single-layered
12
scaffold group
12
scaffold
9
single-layered scaffolds
8
received cellular
8
received cell-free
8
week week
8

Similar Publications

Background: To assess the efficacy and safety of tenecteplase in patients presenting within 24 hours of symptom onset with a large vessel occlusion and target mismatch on perfusion computed tomography.

Methods: ETERNAL-LVO was a prospective, randomized, open-label, blinded end point, phase 3, superiority trial where adult participants with a large vessel occlusion, presenting within 24 hours of onset with salvageable tissue on computed tomography perfusion, were randomized to tenecteplase 0.25 mg/kg or standard care across 11 primary and comprehensive stroke centers in Australia.

View Article and Find Full Text PDF

Background: Limited treatment options exist for infrapopliteal disease in patients with chronic limb-threatening ischemia (CLTI), a condition associated with a high risk of limb loss. Interventional management of diseased infrapopliteal vessels with percutaneous transluminal angioplasty (PTA) is associated with high rates of restenosis and reintervention. In the LIFE-BTK trial, the drug-eluting resorbable scaffold (DRS) demonstrated superior 12-month efficacy compared with PTA in a selected CLTI population with predominantly noncomplex, mildly to moderately calcified lesions.

View Article and Find Full Text PDF

Background: Risk stratification in posterior circulation ischemic stroke (PCIS) is challenging. Although the Posterior Circulation Ischemic Stroke Outcome Score (PCISOS) was developed to address this, its utility in minor PCIS and in identifying homogeneous populations for clinical trials or treatment-responsive subgroups remains uncertain.

Methods: CHANCE-2 (Clopidogrel in High-Risk Patients With Acute Non-disabling Cerebrovascular Events-II) was a multicenter, randomized trial that enrolled patients with minor stroke or high-risk transient ischemic attack who carried CYP2C19 loss-of-function alleles.

View Article and Find Full Text PDF

Introduction: Interstitial lung disease is a major complication in patients with common variable immunodeficiency. There are some publications that try to shed light on the pathophysiology of this non-infectious complication, most of them highlight the role of follicular T cells and CD21 B cells. Moreover, there are no guidelines based on randomized controlled studies on the treatment of patients with interstitial lung disease and the published case series or small uncontrolled studies describe a wide range of response rates to treatment.

View Article and Find Full Text PDF

Background: Mycoplasma pneumoniae pneumonia (MPP) is a common respiratory infection in children, current treatments are limited by resistance and side effects. This study aims to evaluate the clinical efficacy and safety of combining Qingke Mixture with azithromycin for treating MPP in children.

Methods: This prospective, randomized, double-blind, controlled trial included 92 children diagnosed with MPP.

View Article and Find Full Text PDF